• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drugs

  • Print
  • Share
  • E-mail

Brentuximab Vedotin

Pharmacogenomic Information
  

Drug Link
in Drugs@FDA
Therapeutic AreaHUGO
Symbol
Referenced
Subgroup
 
Label Sections with
Pharmacogenomic
Information
Brentuximab
Vedotin
OncologyTNFRSF8CD30 positiveIndications and Usage
Description
Clinical Pharmacology

 

back to Pharmacogenomic Biomarkers in Drug Labeling